Trials / Completed
CompletedNCT03051685
Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Crossover study to compare the BA of DFN-15 at 3 different doses versus the comparator to determine dose-proportionality of DFN-15 in healthy volunteers under fasting conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DFN-15 Dose 1 | |
| DRUG | DFN-15 Dose 2 | |
| DRUG | DFN-15 Dose 3 | |
| DRUG | Active Comparator |
Timeline
- Start date
- 2015-07-20
- Primary completion
- 2015-08-14
- Completion
- 2015-11-10
- First posted
- 2017-02-14
- Last updated
- 2018-02-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03051685. Inclusion in this directory is not an endorsement.